These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2362192)

  • 1. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
    J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo fate of monoclonal antibody B72.3.
    Halpern SE
    J Nucl Med; 1990 Jul; 31(7):1143-6. PubMed ID: 2362193
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
    Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
    Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
    Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
    Simpson J; Schlom J
    Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.
    Khazaeli MB; Saleh MN; Liu TP; Meredith RF; Wheeler RH; Baker TS; King D; Secher D; Allen L; Rogers K
    Cancer Res; 1991 Oct; 51(20):5461-6. PubMed ID: 1913665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
    Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
    Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
    Katari RS; Fernsten PD; Schlom J
    Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
    Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
    Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
    Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
    Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
    Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
    Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
    Divgi CR; Scott AM; Dantis L; Capitelli P; Siler K; Hilton S; Finn RD; Kemeny N; Kelsen D; Kostakoglu L
    J Nucl Med; 1995 Apr; 36(4):586-92. PubMed ID: 7699446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
    Saleh MN; Khazaeli MB; Grizzle WE; Wheeler RH; Lawson S; Liu T; Russel C; Meredith R; Schlom J; LoBuglio AF
    Cancer Res; 1993 Oct; 53(19):4555-62. PubMed ID: 8402627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of 131I-labeled murine monoclonal antibody from patients' blood by intravenous human anti-murine immunoglobulin antibody.
    Stewart JS; Sivolapenko GB; Hird V; Davies KA; Walport M; Ritter MA; Epenetos AA
    Cancer Res; 1990 Feb; 50(3):563-7. PubMed ID: 2297697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
    Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
    Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
    Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST
    Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.